Cargando…
Febrile neutropenia in paediatric oncology
Febrile neutropenia (FN) is a common and dangerous consequence of myelosuppressive chemotherapy but can occur as part of the disease processes. Bacterial bloodstream infection is the most commonly diagnosed cause of febrile neutropenia, with Gram-positive organisms most frequently isolated. However,...
Autores principales: | Davis, Kimberly, Wilson, Shaun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7172100/ https://www.ncbi.nlm.nih.gov/pubmed/32336983 http://dx.doi.org/10.1016/j.paed.2019.12.002 |
Ejemplares similares
-
Evaluation of the clinical Index of Stable febrile neutropenia risk stratification system for management of febrile neutropenia in gynecologic oncology patients
por: Monuszko, Karen A., et al.
Publicado: (2021) -
Re-thinking treatment strategies for febrile neutropenia in paediatric oncology population: the perspective from a developing country
por: James, Vinson, et al.
Publicado: (2021) -
Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
por: Cennamo, Federica, et al.
Publicado: (2021) -
The Pattern of Microorganisms and Drug Susceptibility in Pediatric Oncologic Patients with Febrile Neutropenia
por: Jungrungrueng, Thanyathorn, et al.
Publicado: (2021) -
Meta-ethnography of experiences of early discharge, with a focus on paediatric febrile neutropenia
por: Morgan, Jessica E., et al.
Publicado: (2017)